Avantor (NYSE:AVTR) Now Covered by Analysts at Cleveland Research

Cleveland Research began coverage on shares of Avantor (NYSE:AVTR) in a research note issued to investors on Friday, Briefing.com Automated Import reports. The firm issued a neutral rating on the stock.

A number of other equities analysts also recently commented on the company. Jefferies Financial Group began coverage on Avantor in a report on Tuesday, June 11th. They set a buy rating for the company. Guggenheim began coverage on Avantor in a report on Tuesday, June 11th. They set a buy rating and a $21.00 target price for the company. Raymond James began coverage on Avantor in a report on Wednesday, June 12th. They set an outperform rating and a $20.00 target price for the company. UBS Group began coverage on Avantor in a report on Tuesday, June 11th. They set a buy rating and a $21.00 target price for the company. Finally, Citigroup began coverage on Avantor in a report on Tuesday, June 11th. They set a buy rating and a $21.00 target price for the company. Three investment analysts have rated the stock with a hold rating and eighteen have issued a buy rating to the company. Avantor currently has an average rating of Buy and a consensus price target of $20.81.

Shares of Avantor stock opened at $16.01 on Friday. The company’s 50 day simple moving average is $18.31. Avantor has a 52 week low of $14.00 and a 52 week high of $19.58.

Institutional investors and hedge funds have recently bought and sold shares of the business. Coastal Investment Advisors Inc. bought a new position in Avantor in the second quarter worth $69,000. FTB Advisors Inc. bought a new position in Avantor in the second quarter worth $127,000. Quantitative Systematic Strategies LLC bought a new position in Avantor in the second quarter worth $698,000. Waratah Capital Advisors Ltd. bought a new position in Avantor in the second quarter worth $909,000. Finally, Zweig DiMenna Associates LLC bought a new position in Avantor in the second quarter worth $3,188,000. Institutional investors and hedge funds own 0.05% of the company’s stock.

About Avantor

Avantor, Inc is a provider of mission critical products and services to customers in the biopharma, healthcare, education & government, and advanced technologies & applied materials industries. It sells materials & consumables, equipment & instrumentation and services & specialty procurement. It operates in more than 30 countries and deliver an extensive portfolio of products and services.

Read More: Correction

Analyst Recommendations for Avantor (NYSE:AVTR)

Receive News & Ratings for Avantor Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Avantor and related companies with MarketBeat.com's FREE daily email newsletter.